Alpha Cognition (ACOG) Cash & Equivalents (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Cash & Equivalents of $66.0 million for Q4 2025, up 36.05% year-over-year from $48.5 million in Q4 2024, and up 86.58% quarter-over-quarter from $35.4 million in Q3 2025.
Alpha Cognition (ACOG) Cash & Equivalents (2023 - 2026) Analysis & Trends
Alpha Cognition's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $66.0 million for Q4 2025.
- In Q4 2025, Cash & Equivalents rose 36.05% year-over-year to $66.0 million; the TTM figure through Dec 2025 stood at $66.0 million (up 36.05% YoY), while the FY2025 annual figure was $66.0 million, up 36.05% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $66.0 million, up from $35.4 million in the prior quarter.
- The five-year high for Cash & Equivalents was $66.0 million in Q4 2025, with the low at $1.0 million in Q2 2024.
- The 3-year median for Cash & Equivalents is $37.4 million (2025), against an average of $30.1 million.
- Peak annual rise in Cash & Equivalents reached 3767.57% in 2025, while the deepest fall reached 36.05% in 2025.
- Alpha Cognition's Cash & Equivalents stood at $1.4 million in 2023, then surged by 3357.31% to $48.5 million in 2024, then jumped by 36.05% to $66.0 million in 2025.
- Business Quant data shows ACOG's Cash & Equivalents at $66.0 million in Q4 2025, $35.4 million in Q3 2025, and $39.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 3.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.72 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.71 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.93 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 544.80 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 811.99 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | 41.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.38 Mn |
| Dec 31, 2025 | 66.05 Mn |
| Sep 30, 2025 | 35.40 Mn |
| Jun 30, 2025 | 39.41 Mn |
| Mar 31, 2025 | 45.53 Mn |
| Dec 31, 2024 | 48.55 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.40 Mn |